Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China · Delayed Price · Currency is CNY 18.55
-0.58 (-3.03%)
Jun 18, 2026, 3:00 PM CST
SHA:600529 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,310 | 13,226 | 17,101 | 16,989 | 18,847 | 26,119 | |
Market Cap Growth | -14.48% | -22.66% | 0.66% | -9.86% | -27.84% | -12.46% |
Enterprise Value | 9,611 | 10,709 | 14,307 | 14,571 | 18,195 | 25,062 |
Last Close Price | 18.55 | 19.73 | 24.82 | 24.00 | 26.33 | 40.25 |
PE Ratio | 18.53 | 19.18 | 18.14 | 21.90 | 30.48 | 44.19 |
Forward PE | 15.65 | 12.76 | 15.24 | 17.24 | 22.72 | 39.31 |
PS Ratio | 2.72 | 2.96 | 3.49 | 3.41 | 4.50 | 6.74 |
PB Ratio | 1.47 | 1.60 | 2.14 | 2.26 | 2.71 | 5.59 |
P/TBV Ratio | 1.51 | 1.64 | 2.20 | 2.33 | 2.81 | 5.84 |
P/FCF Ratio | 33.74 | 38.33 | 33.06 | 45.13 | - | - |
P/OCF Ratio | 17.60 | 22.93 | 14.68 | 16.21 | 74.66 | 34.81 |
EV/Sales Ratio | 2.13 | 2.39 | 2.92 | 2.93 | 4.35 | 6.47 |
EV/EBITDA Ratio | 7.78 | 8.76 | 10.10 | 12.41 | 18.99 | 27.27 |
EV/EBIT Ratio | 11.44 | 12.85 | 13.87 | 17.17 | 27.45 | 36.94 |
EV/FCF Ratio | 26.34 | 31.04 | 27.66 | 38.71 | - | - |
Debt / Equity Ratio | 0.01 | 0.01 | - | 0 | 0.00 | - |
Debt / EBITDA Ratio | 0.03 | 0.03 | - | 0.00 | 0.01 | - |
Debt / FCF Ratio | 0.12 | 0.11 | - | 0.01 | - | - |
Net Debt / Equity Ratio | -0.32 | -0.33 | -0.35 | -0.36 | -0.35 | -0.25 |
Net Debt / EBITDA Ratio | -2.19 | -2.21 | -1.97 | -2.28 | -2.56 | -1.30 |
Net Debt / FCF Ratio | -7.40 | -7.85 | -5.39 | -7.12 | 5.34 | 20.27 |
Asset Turnover | 0.45 | 0.44 | 0.50 | 0.55 | 0.55 | 0.64 |
Inventory Turnover | 2.01 | 2.08 | 2.86 | 3.20 | 2.96 | 3.43 |
Quick Ratio | 2.69 | 2.64 | 2.26 | 2.54 | 2.27 | 1.43 |
Current Ratio | 3.79 | 3.76 | 2.99 | 3.21 | 3.02 | 1.99 |
Return on Equity (ROE) | 8.04% | 8.46% | 12.13% | 10.70% | 10.63% | 13.24% |
Return on Assets (ROA) | 5.17% | 5.16% | 6.63% | 5.86% | 5.45% | 7.05% |
Return on Invested Capital (ROIC) | 12.39% | 12.77% | 17.39% | 15.43% | 14.48% | 18.27% |
Return on Capital Employed (ROCE) | 9.90% | 9.90% | 12.70% | 11.20% | 9.40% | 14.30% |
Earnings Yield | 5.42% | 5.21% | 5.51% | 4.57% | 3.28% | 2.26% |
FCF Yield | 2.96% | 2.61% | 3.02% | 2.22% | -2.43% | -0.22% |
Dividend Yield | 2.40% | 2.33% | 2.50% | 1.67% | 1.14% | 0.74% |
Payout Ratio | 55.51% | 53.70% | 49.26% | 25.66% | 28.87% | 30.20% |
Buyback Yield / Dilution | -0.77% | 0.15% | -0.15% | -10.46% | -0.54% | -0.49% |
Total Shareholder Return | 1.66% | 2.48% | 2.35% | -8.79% | 0.60% | 0.26% |